Pharmaceutical Environmental Risk Assessment

Home→ERA Profiles → Barnidipine→

Barnidipine Environmental Risk Assessment (ERA) report

Project-specific environmental risk assessment (ERA) support for human medicinal products and regulatory submissions.

CAS Registry Number
104713-75-9
Molecular formula
C27H29N3O6
Molecular weight
491.5 g/mol
Drug class
Dihydropyridine L-type calcium-channel blockerantihypertensive
Mechanism of action
Inhibits L-type voltage-gated calcium channels in vascular smooth muscle, reducing calcium influx and producing peripheral arterial vasodilation and lower blood pressure.
Indications / reported uses
  • Treatment of essential hypertension in adults where barnidipine products are authorised; not a general indication for acute angina or arrhythmia

Sources: UK product information — Barnidipine · PubMed — Barnidipine pharmacology · FDA product information

View request basketPrefer email? info@toxwriter.com
Phase IPhase II where requiredEU / UK / other markets
Assessment scope

Environmental Risk Assessment (ERA)

ToxWriter provides project-specific support for the Barnidipine Environmental Risk Assessment (ERA) (the Barnidipine ERA report). The required pathway is determined by the medicinal product, active-substance form, route, intended market, use assumptions and available environmental evidence.

Assessment may cover

  • Product, active-substance identity, formulation, route and intended-market review.
  • Phase I environmental exposure screening and applicable trigger evaluation.
  • Phase II environmental fate and ecotoxicity assessment where required by the applicable pathway.
  • PEC/PNEC risk characterisation and PBT/vPvB considerations where relevant and supported by evidence.
  • Data-gap analysis, study strategy, assumptions and scientific reporting.
ERA regulatory framework

The EMA guideline sets out the EU framework for environmental risk assessment of human medicinal products. MHRA guidance describes UK expectations; the applicable scope depends on the product and submission context.